chr19-55014192-C-CGGGA
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PVS1_ModerateBP6_ModerateBS1BS2
The NM_001083899.2(GP6):c.1752_1753insTCCC(p.Gly585SerfsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00592 in 152,220 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0059 ( 11 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
GP6
NM_001083899.2 frameshift
NM_001083899.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.268
Genes affected
GP6 (HGNC:14388): (glycoprotein VI platelet) This gene encodes a platelet membrane glycoprotein of the immunoglobulin superfamily. The encoded protein is a receptor for collagen and plays a critical role in collagen-induced platelet aggregation and thrombus formation. The encoded protein forms a complex with the Fc receptor gamma-chain that initiates the platelet activation signaling cascade upon collagen binding. Mutations in this gene are a cause of platelet-type bleeding disorder-11 (BDPLT11). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0596 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 19-55014192-C-CGGGA is Benign according to our data. Variant chr19-55014192-C-CGGGA is described in ClinVar as [Benign]. Clinvar id is 777546.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00592 (901/152220) while in subpopulation AFR AF= 0.0209 (870/41530). AF 95% confidence interval is 0.0198. There are 11 homozygotes in gnomad4. There are 435 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GP6 | NM_001083899.2 | c.1752_1753insTCCC | p.Gly585SerfsTer7 | frameshift_variant | 8/8 | ENST00000310373.7 | NP_001077368.2 | |
GP6-AS1 | XR_001754012.3 | n.121+7728_121+7729insGGGA | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GP6 | ENST00000310373.7 | c.1752_1753insTCCC | p.Gly585SerfsTer7 | frameshift_variant | 8/8 | 1 | NM_001083899.2 | ENSP00000308782 | ||
GP6-AS1 | ENST00000593060.5 | n.155+7728_155+7729insGGGA | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00594 AC: 903AN: 152102Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
903
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00125 AC: 185AN: 147996Hom.: 1 AF XY: 0.000919 AC XY: 74AN XY: 80484
GnomAD3 exomes
AF:
AC:
185
AN:
147996
Hom.:
AF XY:
AC XY:
74
AN XY:
80484
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000722 AC: 413AN: 571810Hom.: 1 Cov.: 6 AF XY: 0.000543 AC XY: 168AN XY: 309542
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
413
AN:
571810
Hom.:
Cov.:
6
AF XY:
AC XY:
168
AN XY:
309542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00592 AC: 901AN: 152220Hom.: 11 Cov.: 32 AF XY: 0.00585 AC XY: 435AN XY: 74420
GnomAD4 genome
AF:
AC:
901
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
435
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
GP6-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at